TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?

被引:13
|
作者
Riku, Yuichi [1 ,2 ]
Yoshida, Mari [1 ]
Iwasaki, Yasushi [1 ]
Sobue, Gen [3 ]
Katsuno, Masahisa [2 ,4 ]
Ishigaki, Shinsuke [5 ]
机构
[1] Aichi Med Univ, Inst Med Sci Aging, Nagakute 4801195, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya 7448550, Japan
[3] Aichi Med Univ, Grad Sch Med, Nagakute 4801195, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Clin Res Educ, Nagoya 7448550, Japan
[5] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu 5202192, Japan
基金
日本学术振兴会;
关键词
AD; ALS; CBD; FTLD; LATE; PART; PSP; TDP-43; SFPQ; tau; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE SUPRANUCLEAR PALSY; GRANULOVACUOLAR DEGENERATION; ALZHEIMERS-DISEASE; CORTICOBASAL DEGENERATION; TAU PATHOLOGY; MOUSE MODEL; NEUROPATHOLOGICAL CRITERIA;
D O I
10.3390/ijms232415755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transactivation response DNA binding protein 43 kDa (TDP-43) and tau are major pathological proteins of neurodegenerative disorders, of which neuronal and glial aggregates are pathological hallmarks. Interestingly, accumulating evidence from neuropathological studies has shown that comorbid TDP-43 pathology is observed in a subset of patients with tauopathies, and vice versa. The concomitant pathology often spreads in a disease-specific manner and has morphological characteristics in each primary disorder. The findings from translational studies have suggested that comorbid TDP-43 or tau pathology has clinical impacts and that the comorbid pathology is not a bystander, but a part of the disease process. Shared genetic risk factors or molecular abnormalities between TDP-43 proteinopathies and tauopathies, and direct interactions between TDP-43 and tau aggregates, have been reported. Further investigations to clarify the pathogenetic factors that are shared by a broad spectrum of neurodegenerative disorders will establish key therapeutic targets.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] TDP-43 proteinopathy in progressive supranuclear palsy (PSP)
    Massey, L.
    Lashley, T.
    O'Sullivan, S. S.
    Phadke, R.
    Moriyama-Silveira, L.
    Lees, A.
    Holton, J.
    Revesz, T.
    MOVEMENT DISORDERS, 2008, 23 (01) : S37 - S37
  • [32] Perry syndrome is a distinctive type of TDP-43 proteinopathy
    Mishima, T.
    Koga, S.
    Lin, W. L.
    Kasanuki, K.
    Castanedes-Casey, M.
    Wszolek, Z.
    Oh, S. J.
    Tsuboi, Y.
    Dickson, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 582 - 582
  • [33] Endogenous retroviruses can propagate TDP-43 proteinopathy
    Ferreiro, Maria E.
    Faulkner, Geoffrey J.
    TRENDS IN NEUROSCIENCES, 2023, 46 (06) : 413 - 414
  • [34] Perry's syndrome is a unique TDP-43 proteinopathy
    Wider, C.
    Dickson, D.
    Calne, D.
    Stoessl, J.
    Gutmann, L.
    Calne, S.
    Brown, L.
    Wszolek, Z.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S88 - S89
  • [35] Molecular analysis and biochemical classification of TDP-43 proteinopathy
    Tsuji, Hiroshi
    Arai, Tetsuaki
    Kametani, Fuyuki
    Nonaka, Takashi
    Yamashita, Makiko
    Suzukake, Masami
    Hosokawa, Masato
    Yoshida, Mari
    Hatsuta, Hiroyuki
    Takao, Masaki
    Saito, Yuko
    Murayama, Shigeo
    Akiyama, Haruhiko
    Hasegawa, Masato
    Mann, David M. A.
    Tamaoka, Akira
    BRAIN, 2012, 135 : 3380 - 3391
  • [36] Molecular analysis and biochemical classification of TDP-43 proteinopathy
    Hasegawa, Masato
    Tsuji, Hiroshi
    Arai, Tetsuaki
    Kametani, Fuyuki
    Nonaka, Takashi
    Yamashita, Makiko
    Suzukake, Masami
    Hosokawa, Masato
    Yoshida, Mari
    Hatsuta, Hiroyuki
    Takao, Masaki
    Saito, Yuko
    Murayama, Shigeo
    Mann, David
    Akiyama, Haruhiko
    Akira, Tamaoka
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 103 - 104
  • [37] Identification of TDP-43 modifying kinases in a C. elegans model of TDP-43 proteinopathy.
    Liachko, Nicole F.
    Guthrie, Chris R.
    Kraemer, Brian C.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 277 - 277
  • [38] Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy
    Mishima, Takayasu
    Koga, Shunsuke
    Lin, Wen-Lang
    Kasanuki, Koji
    Castanedes-Casey, Monica
    Wszolek, Zbigniew K.
    Oh, Shin J.
    Tsuboi, Yoshio
    Dickson, Dennis W.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (08): : 676 - 682
  • [39] RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
    Necarsulmer, Julie C.
    Simon, Jeremy M.
    Evangelista, Baggio A.
    Chen, Youjun
    Tian, Xu
    Nafees, Sara
    Marquez, Ariana B.
    Jiang, Huijun
    Wang, Ping
    Ajit, Deepa
    Nikolova, Viktoriya D.
    Harper, Kathryn M.
    Ezzell, J. Ashley
    Lin, Feng-Chang
    Beltran, Adriana S.
    Moy, Sheryl S.
    Cohen, Todd J.
    ELIFE, 2023, 12
  • [40] Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
    Arai, Tetsuaki
    Hasegawa, Masato
    Nonoka, Takashi
    Kametani, Fuyuki
    Yamashita, Makiko
    Hosokawa, Masato
    Niizato, Kazuhiro
    Tsuchiya, Kuniaki
    Kobayashi, Zen
    Ikeda, Kenji
    Yoshida, Mari
    Onaya, Mitsumoto
    Fujishiro, Hiroshige
    Akiyama, Haruhiko
    NEUROPATHOLOGY, 2010, 30 (02) : 170 - 181